Mar 24, 2017 at 21:12 | Source: CNBC-TV18
An inspection by the US Food and Drug Administration took place at the sterile injectables manufacturing unit between March 9 and 17.
Mar 24, 2017 at 15:50 | Source: CNBC-TV18
Dr. Reddys said it spent about $35-40 million on remediation work that includes legal and professional charges.
Mar 05, 2017 at 11:57 | Source: Moneycontrol.com
Cipla has made many changes to its top leadership as it tries to catch up with other larger Indian generic rivals like Sun Pharma, Dr.Reddys, Lupin and Aurobindo in the US market who generate half their sales at much higher margins.
Mar 02, 2017 at 08:01 | Source: CNBC-TV18
Tata Motors | TCS | Wipro | HDFC Bank | Lupin | ICICI Bank | Hero Motocorp | Panacea Biotec | Grasim | Wockhardt | NMDC | HCL Technologies | Glenmark | Geometric | Sun Pharma | Trigyn Tech and Bartronics are stocks, which are in the news today.
Mar 01, 2017 at 21:20 | Source: CNBC-TV18
The Indian Pharmaceutical Alliance a powerful grouping of twenty leading Indian drug companies has written to Arvind Panagariya, vice chairman of the National Institution for Transforming India or NITI Aayog, expressing concerns over the recent decisions of the government.
Mar 01, 2017 at 11:01 | Source: CNBC-TV18
Ample liquidity in the market could help it go up further but one needs be cautious of the risk-reward balance from a fundamental perspective, says Sanjeev Prasad, Senior Executive Director & Co-Head, Kotak Institutional Equities.
Feb 27, 2017 at 22:02 | Source: CNBC-TV18
The 2-day Indian Pharma Alliance Conference concluded on Friday and speaking at the conference, Founder and MD of Sun Pharma, Dilip Shanghvi as well as Pankaj Patel of Zydus Cadila say that efforts are underway to meet global quality standards in both products and processes.
Feb 27, 2017 at 16:04 | Source: PTI
The CLMV nations (Cambodia, Laos, Myanmar and Vietnam) enjoy duty benefits under the Generalised Scheme of Preferences (GSPs) of developed countries like the US and EU and this can be an attractive incentive for domestic units to set up manufacturing facilities there.
Feb 27, 2017 at 12:25 | Source: CNBC-TV18
India is the key supplier of generic medicines to both US and UK and other parts of Europe. So, it is not surprising that the focus is on India, said Gerald W Heddell, Director-Inspection, Medicines and Healthcare products Regulatory Agency (MHRA).
Feb 23, 2017 at 22:00 | Source: CNBC-TV18
There's no end in sight for the Indian pharmaceutical industry's struggles with domestic and foreign drug regulators. It's true that quite a few companies have received clean chits from regulators in the US, UK and Europe. However, at the same time, new issues have also been cropping up with disturbing frequency.